Barry Simon

Develops drugs for the treatment of cancer

Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics

Engages in the discovery and development of drugs and therapies

Develops and commercializes dermatology products

Develops and produces cancer treatment products

Develops and produces medical tests and digital tools

HealthPro BioVentures serves the biotechnology, biomedical, healthcare and pharmaceutical sectors. Their purpose is to define, enhance and realize value for their clients by leveraging their experience, resources and network of relationships. The firm seeks to provide unparalleled services to meet the needs of the life sciences sector, from large corporate entities to emerging companies. HealthPro originally emerged from DavosPharma. They draw on extensive contacts through their relationships and association with DavosPharma. As a result, HealthPro has a network of both buy-side and sell-side healthcare opportunities. HealthPro BioVentures' services include the development of strategic and tactical themes and target lists of potential partners, access to their vast, proprietary library of available compounds, assisting with presentations and due diligence dossiers, analysis of the synergies of potential strategic partners, advising on structure, timing and pricing of transactions and assisting with negotiation, documentation and closing of transactions. HealthPro targets potential partners and investors to assist both public and private companies who are looking to acquire a strategic target company or product. The firm's portfolio of services allows them to represent life sciences companies that are either interested in being acquired or interested in investing specific assets. In both by-side and sell-side transactions, their focus is on developing transactions that are mutually beneficial to both the buyer and the seller.

Functions as a College/University

North Sound is a global long/short equity hedge fund manager. Though not limited by sector, they tend to focus on large-cap companies in the finance, communications, retail, energy and consumer services sectors.